AKBA vs NVS
Akebia Ther (AKBA) versus NVS (NVS) — a side-by-side from cached financials, not a winner call.
Akebia Ther (AKBA) is a drug manufacturers - specialty & generic company listed on US.
NVS (NVS) common stock.
Latest reported AKBA revenue for 2026-06-30 was $102.7M. Net income was -$18.0M. Revenue was up 91.8% from 2026-03-31 to 2026-06-30. AKBA currently screens at market cap $260.1M.
NVS does not have a complete income-statement cache yet.
AKBA currently screens at market cap $260.1M. NVS currently screens at market cap $0.
Not investment advice. Open the AKBA and NVS stock pages for the full models.
Not investment advice.